About Konstantina Konstantinopoulou

This author has not yet filled in any details.
So far Konstantina Konstantinopoulou has created 21 blog entries.

Webinar – Document QC: A discipline in its own right

2021-06-24T14:44:17+00:00

Document QC: A discipline in its own right Download the webinar recording to learn more about the value of dedicated quality control in medical writing and we hope you find the webinar to be informative and insightful.  Download [...]

Webinar – Document QC: A discipline in its own right2021-06-24T14:44:17+00:00

Document QC: A discipline in its own right Webinar

2021-06-24T15:09:14+00:00

The number and complexity of regulatory documents has increased significantly in the last decade as the volume of clinical trials and the regulatory burden have grown. The expedited clinical research for Covid -19 vaccines and therapeutics has further demonstrated the need for rapidly generating high quality regulatory documents to ensure patient safety [...]

Document QC: A discipline in its own right Webinar2021-06-24T15:09:14+00:00

KASA system

2020-12-03T16:30:12+00:00

KASA System FDA’s regulatory assessment has evolved from a summary-based review to a question and risk-based review with an integrated quality assessment. Over the years, the FDA has focused on the challenges of efficiency, consistency, and objectivity in its oversight of pharmaceutical quality. To [...]

KASA system2020-12-03T16:30:12+00:00

The Value of Patient Voices in Plain Language Summaries Webinar

2020-12-07T09:51:24+00:00

Plain language summaries (PLSs) aim to meet a need in the industry for clinical trial transparency in a way that is meaningful and understandable for patients and the general public. As the pharmaceutical industry steps up to meet this requirement, patient panels play a crucial role in ensuring that information shared by sponsors [...]

The Value of Patient Voices in Plain Language Summaries Webinar2020-12-07T09:51:24+00:00

FDA Guidance for Industry: Expiration Dating of Unit-Dose Repackaged Solid Oral Dosage Form Drug Products

2020-12-07T09:35:36+00:00

FDA Guidance for Industry: Expiration Dating of Unit-Dose Repackaged Solid Oral Dosage Form Drug Products Summary: The USFDA recently finalized the guidance for industry entitled “Expiration Dating of Unit-Dose Repackaged Solid Oral Dosage Form Drug Products”. This guidance addresses repackaging of prescription and [...]

FDA Guidance for Industry: Expiration Dating of Unit-Dose Repackaged Solid Oral Dosage Form Drug Products2020-12-07T09:35:36+00:00

US Agent & Official Correspondent (OC) Services

2020-12-07T09:53:14+00:00

US Agent & Official Correspondent (OC) Services Are you planning to register and market your pharmaceutical, medical device or food and dietary supplement in the US? Do you have a US agent? All non-U.S. Food, Beverage, Dietary Supplement, Medical Device or Drug companies who [...]

US Agent & Official Correspondent (OC) Services2020-12-07T09:53:14+00:00
Go to Top